TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4441659
log Bayes Factor = <0.0001
Chromosome 3   position 108,851,791  (GRCh37) Explore rs4441659 on Ensembl!
Variant rs4441659 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
Z03.1 Observation for suspected malignant neoplasm
0.017 0.983 0.000
Y42.7 Androgens and anabolic congeners
0.000 0.990 0.010
Y42.5 Other oestrogens and progestogens
0.000 0.990 0.010
R49.0 Dysphonia
0.010 0.990 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.990 0.010
C97 Malignant neoplasms of independent (primary) multiple sites
0.000 0.991 0.009
J02.9 Acute pharyngitis, unspecified
0.009 0.991 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.991 0.009
C22.9 Liver, unspecified
0.000 0.992 0.008
F60.3 Emotionally unstable personality disorder
0.000 0.992 0.008
F60 Specific personality disorders
0.000 0.992 0.008
Z02.8 Other examinations for administrative purposes
0.000 0.993 0.007
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.993 0.007
Y42.9 Other and unspecified hormone antagonists
0.000 0.993 0.007
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.000 0.993 0.007
Z34.8 Supervision of other normal pregnancy
0.007 0.993 0.000
Y42.4 Oral contraceptives
0.000 0.993 0.007
F60.7 Dependent personality disorder
0.000 0.993 0.007
Y42.2 Antithyroid drugs
0.000 0.993 0.007
F60.9 Personality disorder, unspecified
0.000 0.993 0.007
F60.2 Dissocial personality disorder
0.000 0.993 0.007
Y42.1 Thyroid hormones and substitutes
0.000 0.993 0.007
C22.0 Liver cell carcinoma
0.000 0.993 0.007
N84.0 Polyp of corpus uteri
0.000 0.993 0.007
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms
0.007 0.993 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.993 0.006
C21.1 Anal canal
0.000 0.994 0.006
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.994 0.006
K83.1 Obstruction of bile duct
0.000 0.994 0.006
C22.1 Intrahepatic bile duct carcinoma
0.000 0.994 0.006
C21 Malignant neoplasm of anus and anal canal
0.000 0.994 0.006
F60.0 Paranoid personality disorder
0.000 0.994 0.006
F60.6 Anxious [avoidant] personality disorder
0.000 0.994 0.006
F60.1 Schizoid personality disorder
0.000 0.994 0.006
F60.4 Histrionic personality disorder
0.000 0.994 0.006
C21.0 Anus, unspecified
0.000 0.994 0.006
M22.2 Patellofemoral disorders
0.006 0.994 0.000
F60.5 Anankastic personality disorder
0.000 0.994 0.005
C22.7 Other specified carcinomas of liver
0.000 0.995 0.005
C22.4 Other sarcomas of liver
0.000 0.995 0.005
C22.3 Angiosarcoma of liver
0.000 0.995 0.005
C22.2 Hepatoblastoma
0.000 0.995 0.005
Y84.2 Radiological procedure and radiotherapy
0.000 0.995 0.005
F60.8 Other specific personality disorders
0.000 0.995 0.005
C20 Malignant neoplasm of rectum
0.000 0.995 0.005
R49 Voice disturbances
0.005 0.995 0.000
L89.1 Stage II decubitus ulcer
0.005 0.995 0.000
C15-C26 Malignant neoplasms of digestive organs
0.000 0.995 0.005
C21.8 Overlapping lesion of rectum, anus and anal canal
0.000 0.995 0.004
C21.2 Cloacogenic zone
0.000 0.995 0.004
K83 Other diseases of biliary tract
0.000 0.996 0.004
I25.1 Atherosclerotic heart disease
0.000 0.996 0.004
K83.9 Disease of biliary tract, unspecified
0.000 0.996 0.004
Z34.0 Supervision of normal first pregnancy
0.004 0.996 0.000
R49.1 Aphonia
0.004 0.996 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.000 0.996 0.004
K83.8 Other specified diseases of biliary tract
0.000 0.996 0.004
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.000 0.996 0.004
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.000 0.996 0.004
Z34 Supervision of normal pregnancy
0.004 0.996 0.000
M22 Disorders of patella
0.004 0.996 0.000
C23 Malignant neoplasm of gallbladder
0.000 0.996 0.004
R49.2 Hypernasality and hyponasality
0.004 0.996 0.000
C24.9 Biliary tract, unspecified
0.000 0.996 0.004
C17 Malignant neoplasm of small intestine
0.000 0.996 0.004
C26.9 Ill-defined sites within the digestive system
0.000 0.997 0.003
C26.0 Intestinal tract, part unspecified
0.000 0.997 0.003
M22.3 Other derangements of patella
0.003 0.997 0.000
R49.8 Other and unspecified voice disturbances
0.003 0.997 0.000
C24.1 Ampulla of Vater
0.000 0.997 0.003
K83.5 Biliary cyst
0.000 0.997 0.003
K83.4 Spasm of sphincter of Oddi
0.000 0.997 0.003
K83.2 Perforation of bile duct
0.000 0.997 0.003
O82.1 Delivery by emergency Caesarean section
0.003 0.997 0.000
T93.8 Sequelae of other specified injuries of lower limb
0.000 0.997 0.003
M22.0 Recurrent dislocation of patella
0.003 0.997 0.000
K83.3 Fistula of bile duct
0.000 0.997 0.003
J02 Acute pharyngitis
0.003 0.997 0.000
C17.0 Duodenum
0.000 0.997 0.003
C26.8 Overlapping lesion of digestive system
0.000 0.997 0.003
C26.1 Spleen
0.000 0.997 0.003
M22.9 Disorder of patella, unspecified
0.003 0.997 0.000
C24.8 Overlapping lesion of biliary tract
0.000 0.997 0.003
Z02 Examination and encounter for administrative purposes
0.000 0.997 0.003
M22.4 Chondromalacia patellae
0.003 0.997 0.000
Y41.5 Antiviral drugs
0.000 0.997 0.003
I95.9 Hypotension, unspecified
0.000 0.997 0.003
M22.1 Recurrent subluxation of patella
0.003 0.997 0.000
B24 Unspecified human immunodeficiency virus [HIV] disease
0.000 0.997 0.003
C17.9 Small intestine, unspecified
0.000 0.997 0.003
C17.8 Overlapping lesion of small intestine
0.000 0.997 0.003
C17.3 Meckel's diverticulum
0.000 0.997 0.003
C17.1 Jejunum
0.000 0.997 0.003
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.997 0.003
G95.9 Disease of spinal cord, unspecified
0.000 0.997 0.003
H01.0 Blepharitis
0.000 0.997 0.003
O63.0 Prolonged first stage (of labour)
0.003 0.997 0.000
C24.0 Extrahepatic bile duct
0.000 0.997 0.003
O82 Single delivery by Caesarean section
0.003 0.997 0.000
F60-F69 Disorders of adult personality and behaviour
0.000 0.997 0.003
O82.0 Delivery by elective Caesarean section
0.003 0.997 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.000 0.997 0.003
Y41.0 Sulphonamides
0.000 0.997 0.003
M22.8 Other disorders of patella
0.003 0.997 0.000
Z04.9 Examination and observation for unspecified reason
0.003 0.997 0.000
Y43.1 Antineoplastic antimetabolites
0.000 0.997 0.003
C17.2 Ileum
0.000 0.997 0.002
Y49.2 Other and unspecified antidepressants
0.000 0.997 0.002
Z02.9 Examination for administrative purposes, unspecified
0.000 0.997 0.002
Z02.7 Issue of medical certificate
0.000 0.997 0.002
Z02.6 Examination for insurance purposes
0.000 0.997 0.002
Z02.5 Examination for participation in sport
0.000 0.997 0.002
Z02.4 Examination for driving licence
0.000 0.997 0.002
Z02.3 Examination for recruitment to armed forces
0.000 0.997 0.002
Z02.2 Examination for admission to residential institution
0.000 0.997 0.002
Z02.1 Pre-employment examination
0.000 0.997 0.002
Z02.0 Examination for admission to educational institution
0.000 0.997 0.002
C25 Malignant neoplasm of pancreas
0.000 0.997 0.003
Y44 Agents primarily affecting blood constituents
0.000 0.997 0.003
O82.9 Delivery by Caesarean section, unspecified
0.002 0.997 0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)
0.000 0.997 0.002
D13.2 Duodenum
0.000 0.997 0.003
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified
0.000 0.997 0.002
I51.7 Cardiomegaly
0.003 0.997 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.998 0.002
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.998 0.002
M22.10 Recurrent subluxation of patella, unspecified knee
0.002 0.998 0.000
J02.0 Streptococcal pharyngitis
0.002 0.998 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.998 0.002
Y41.1 Antimycobacterial drugs
0.000 0.998 0.002
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.998 0.002
F64 Gender identity disorders
0.000 0.998 0.002
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.998 0.002
M41.99 Scoliosis, unspecified (Site unspecified)
0.002 0.998 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.998 0.002
Y41.4 Anthelminthics
0.000 0.998 0.002
Y41.3 Other antiprotozoal drugs
0.000 0.998 0.002
I46.9 Cardiac arrest, unspecified
0.000 0.998 0.002
F61 Mixed and other personality disorders
0.000 0.998 0.002
H35.4 Peripheral retinal degeneration
0.000 0.998 0.002
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.000 0.998 0.002
F65 Disorders of sexual preference
0.000 0.998 0.002
F63 Habit and impulse disorders
0.000 0.998 0.002
Y43 Primarily systemic agents
0.000 0.998 0.002
O00.1 Tubal pregnancy
0.002 0.998 0.000
O82.8 Other single delivery by Caesarean section
0.002 0.998 0.000
O82.2 Delivery by Caesarean hysterectomy
0.002 0.998 0.000
S29.9 Unspecified injury of thorax
0.000 0.998 0.002
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.998 0.002
C16 Malignant neoplasm of stomach
0.000 0.998 0.002
F68 Other disorders of adult personality and behaviour
0.000 0.998 0.002
J02.8 Acute pharyngitis due to other specified organisms
0.002 0.998 0.000
Y44.2 Anticoagulants
0.000 0.998 0.002
T90.4 Sequelae of injury of eye and orbit
0.000 0.998 0.002
C16.6 Greater curvature of stomach, unspecified
0.000 0.998 0.002
C25.7 Other parts of pancreas
0.000 0.998 0.002
C16.1 Fundus of stomach
0.000 0.998 0.002
Y44.6 Natural blood and blood products
0.000 0.998 0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.998 0.002
C25.4 Endocrine pancreas
0.000 0.998 0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.998 0.002
F62 Enduring personality changes, not attributable to brain damage and disease
0.000 0.998 0.002
I49.0 Ventricular fibrillation and flutter
0.002 0.998 0.000
W06.0 Home
0.002 0.998 0.000
B18.2 Chronic viral hepatitis C
0.000 0.998 0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.002 0.998 0.000
Y44.5 Thrombolytic drugs
0.000 0.998 0.002
K01.1 Impacted teeth
0.000 0.998 0.002
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.998 0.002
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.998 0.002
Y44.7 Plasma substitutes
0.000 0.998 0.002
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.998 0.002
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.998 0.002
C25.1 Body of pancreas
0.000 0.998 0.002
C25.8 Overlapping lesion of pancreas
0.000 0.998 0.002
K83.0 Cholangitis
0.000 0.998 0.002
R90.0 Intracranial space-occupying lesion
0.000 0.998 0.002
B18.1 Chronic viral hepatitis B without delta-agent
0.000 0.998 0.002
F69 Unspecified disorder of adult personality and behaviour
0.000 0.998 0.002
Y59 Other and unspecified vaccines and biological substances
0.000 0.998 0.002
F64.0 Transsexualism
0.000 0.998 0.002
Y49.9 Psychotropic drug, unspecified
0.000 0.998 0.002
Y49.7 Psychostimulants with abuse potential
0.000 0.998 0.002
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.998 0.002
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.998 0.002
Y43.2 Antineoplastic natural products
0.000 0.998 0.002
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.998 0.002
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.998 0.002
F64.9 Gender identity disorder, unspecified
0.000 0.998 0.002
F64.8 Other gender identity disorders
0.000 0.998 0.002
F64.2 Gender identity disorder of childhood
0.000 0.998 0.002
F64.1 Dual-role transvestism
0.000 0.998 0.002
I44.0 Atrioventricular block, first degree
0.002 0.998 0.000
M06.9 Rheumatoid arthritis, unspecified
0.002 0.998 0.000
S30.0 Contusion of lower back and pelvis
0.002 0.998 0.000
Y49.5 Other antipsychotics and neuroleptics
0.000 0.998 0.002
Z40 Prophylactic surgery
0.002 0.998 0.000
B23.8 HIV disease resulting in other specified conditions
0.000 0.998 0.002
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.998 0.002
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.002 0.998 0.000
F63.9 Habit and impulse disorder, unspecified
0.000 0.998 0.002
F63.8 Other habit and impulse disorders
0.000 0.998 0.002
F63.3 Trichotillomania
0.000 0.998 0.002
F63.2 Pathological stealing [kleptomania]
0.000 0.998 0.002
F63.1 Pathological fire-setting [pyromania]
0.000 0.998 0.002
F63.0 Pathological gambling
0.000 0.998 0.002
F65.9 Disorder of sexual preference, unspecified
0.000 0.998 0.002
F65.8 Other disorders of sexual preference
0.000 0.998 0.002
F65.6 Multiple disorders of sexual preference
0.000 0.998 0.002
F65.5 Sadomasochism
0.000 0.998 0.002
F65.4 Paedophilia
0.000 0.998 0.002
F65.3 Voyeurism
0.000 0.998 0.002
F65.2 Exhibitionism
0.000 0.998 0.002
F65.1 Fetishistic transvestism
0.000 0.998 0.002
F65.0 Fetishism
0.000 0.998 0.002
F66.9 Psychosexual development disorder, unspecified
0.000 0.998 0.002
F66.8 Other psychosexual development disorders
0.000 0.998 0.002
F66.2 Sexual relationship disorder
0.000 0.998 0.002
F66.1 Egodystonic sexual orientation
0.000 0.998 0.002
F66.0 Sexual maturation disorder
0.000 0.998 0.002
Y43.9 Primarily systemic agent, unspecified
0.000 0.998 0.002
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.998 0.002
Y43.6 Enzymes, not elsewhere classified
0.000 0.998 0.002
Y43.5 Acidifying and alkalising agents
0.000 0.998 0.002
Y57.9 Drug or medicament, unspecified
0.000 0.998 0.002
C25.3 Pancreatic duct
0.000 0.998 0.002
C25.2 Tail of pancreas
0.000 0.998 0.002
E13.9 Without complications
0.000 0.998 0.002
F68.8 Other specified disorders of adult personality and behaviour
0.000 0.998 0.002
F68.0 Elaboration of physical symptoms for psychological reasons
0.000 0.998 0.002
K55.2 Angiodysplasia of colon
0.002 0.998 0.000
Y43.3 Other antineoplastic drugs
0.000 0.998 0.002
I97 Postprocedural disorders of circulatory system, not elsewhere classified
0.000 0.998 0.002
C16.4 Pylorus
0.000 0.998 0.002
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.000 0.998 0.002
Y58 Bacterial vaccines
0.000 0.998 0.002
K74.6 Other and unspecified cirrhosis of liver
0.000 0.998 0.002
Y57 Other and unspecified drugs and medicaments
0.000 0.998 0.002
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M00.9 Pyogenic arthritis, unspecified
0.000 0.998 0.002
S30.1 Contusion of abdominal wall
0.002 0.998 0.000
C16.5 Lesser curvature of stomach, unspecified
0.000 0.998 0.002
C25.0 Head of pancreas
0.000 0.998 0.002
Y59.3 Immunoglobulin
0.000 0.998 0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.998 0.002
C16.2 Body of stomach
0.000 0.998 0.002
F62.8 Other enduring personality changes
0.000 0.998 0.002
F62.1 Enduring personality change after psychiatric illness
0.000 0.998 0.002
F62.0 Enduring personality change after catastrophic experience
0.000 0.998 0.002
L89.9 Decubitus ulcer and pressure area, unspecified
0.002 0.998 0.000
T93 Sequelae of injuries of lower limb
0.000 0.998 0.002
Z90.7 Acquired absence of genital organ(s)
0.000 0.998 0.002
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions
0.000 0.998 0.002
M00.92 Pyogenic arthritis, unspecified (Upper arm)
0.000 0.998 0.002
H58.8 Visual disturbances in diseases classified elsewhere
0.000 0.998 0.002
I49.8 Other specified cardiac arrhythmias
0.002 0.998 0.000
N80.0 Endometriosis of uterus
0.000 0.998 0.002
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.000 0.998 0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.998 0.002
L89 Decubitus ulcer
0.002 0.998 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.998 0.002
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.998 0.002
N42.9 Disorder of prostate, unspecified
0.002 0.998 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.002 0.998 0.000
M62.86 Other specified disorders of muscle (Lower leg)
0.002 0.998 0.000
M62.80 Other specified disorders of muscle (Multiple sites)
0.002 0.998 0.000
C16.8 Overlapping lesion of stomach
0.000 0.998 0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.998 0.002
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.002 0.998 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.000 0.998 0.002
Y43.0 Antiallergic and antiemetic drugs
0.000 0.998 0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.998 0.002
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.998 0.002
Y59.9 Vaccine or biological substance, unspecified
0.000 0.998 0.002
Y59.8 Other specified vaccines and biological substances
0.000 0.998 0.002
Y59.2 Protozoal vaccines
0.000 0.998 0.002
Y59.1 Rickettsial vaccines
0.000 0.998 0.002
Y59.0 Viral vaccines
0.000 0.998 0.002
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.998 0.001
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.002 0.998 0.000
F62.9 Enduring personality change, unspecified
0.000 0.998 0.001
Z40.9 Prophylactic surgery, unspecified
0.002 0.998 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.000 0.998 0.002
M06.98 Rheumatoid arthritis, unspecified (Other)
0.002 0.998 0.000
I97.1 Other functional disturbances following cardiac surgery
0.000 0.998 0.002
Y54.8 Agents affecting uric acid metabolism
0.000 0.998 0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.002 0.998 0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)
0.000 0.998 0.002
M00.90 Pyogenic arthritis, unspecified (Multiple sites)
0.000 0.998 0.002
C16.3 Pyloric antrum
0.000 0.998 0.001
H35.7 Separation of retinal layers
0.000 0.998 0.002
Y54.0 Mineralocorticoids
0.000 0.998 0.002
B18 Chronic viral hepatitis
0.000 0.998 0.002
S30 Superficial injury of abdomen, lower back and pelvis
0.002 0.998 0.000
M00.93 Pyogenic arthritis, unspecified (Forearm)
0.000 0.998 0.002
G12.2 Motor neuron disease
0.002 0.998 0.000
I97.0 Postcardiotomy syndrome
0.000 0.998 0.002
S30.8 Other superficial injuries of abdomen, lower back and pelvis
0.002 0.998 0.000
T94.1 Sequelae of injuries, not specified by body region
0.000 0.998 0.002
Y45.2 Propionic acid derivatives
0.000 0.998 0.002
Y45.0 Opioids and related analgesics
0.000 0.998 0.002
Y50.9 Central nervous system stimulant, unspecified
0.000 0.998 0.001
Y50.8 Other central nervous system stimulants
0.000 0.998 0.001
Y50.1 Opioid receptor antagonists
0.000 0.998 0.001
Y50.0 Analeptics
0.000 0.998 0.001
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.998 0.001
M06.37 Rheumatoid nodule (Ankle and foot)
0.002 0.998 0.000
F20.0 Paranoid schizophrenia
0.000 0.998 0.002
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere
0.000 0.998 0.002
N92.3 Ovulation bleeding
0.002 0.998 0.000
T91.8 Sequelae of other specified injuries of neck and trunk
0.000 0.998 0.002
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.998 0.001
Y57.6 Other diagnostic agents
0.000 0.998 0.001
M00.99 Pyogenic arthritis, unspecified (Site unspecified)
0.000 0.998 0.001
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)
0.002 0.998 0.000
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)
0.002 0.998 0.000
F20.9 Schizophrenia, unspecified
0.000 0.998 0.002
I97.9 Postprocedural disorder of circulatory system, unspecified
0.000 0.998 0.001
N60.4 Mammary duct ectasia
0.002 0.998 0.000
S30.2 Contusion of external genital organs
0.002 0.998 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.998 0.002
Y58.9 Other and unspecified bacterial vaccines
0.000 0.998 0.001
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.998 0.001
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.998 0.001
Y58.5 Diphtheria vaccine
0.000 0.998 0.001
Y58.4 Tetanus vaccine
0.000 0.998 0.001
Y58.3 Plague vaccine
0.000 0.998 0.001
Y58.2 Cholera vaccine
0.000 0.998 0.001
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.998 0.001
Z34.9 Supervision of normal pregnancy, unspecified
0.002 0.998 0.000
I95 Hypotension
0.000 0.998 0.002
Y45.5 4-Aminophenol derivatives
0.000 0.998 0.002
Y57.7 Vitamins, not elsewhere classified
0.000 0.998 0.001
Y57.4 Pharmaceutical excipients
0.000 0.998 0.001
Y57.3 Alcohol deterrents
0.000 0.998 0.001
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.998 0.001
Y57.1 Lipotropic drugs
0.000 0.998 0.001
Y57.0 Appetite depressants [anorectics]
0.000 0.998 0.001
G95 Other diseases of spinal cord
0.000 0.998 0.002
M00.98 Pyogenic arthritis, unspecified (Other)
0.000 0.998 0.001
M00.91 Pyogenic arthritis, unspecified (Shoulder region)
0.000 0.998 0.001
M41.9 Scoliosis, unspecified
0.002 0.998 0.000
T84.2 Mechanical complication of internal fixation device of other bones
0.002 0.998 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.998 0.001
Y54.9 Mineral salts, not elsewhere classified
0.000 0.998 0.001
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.998 0.001
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.998 0.001
C66 Malignant neoplasm of ureter
0.000 0.998 0.002
Y48 Anaesthetics and therapeutic gases
0.000 0.998 0.001
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.998 0.001
D89.2 Hypergammaglobulinaemia, unspecified
0.002 0.998 0.000
T93.4 Sequelae of injury of nerve of lower limb
0.000 0.998 0.001
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.998 0.001
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.998 0.001
B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
0.000 0.998 0.001
B23.1 HIV disease resulting in (persistent) generalised lymphadenopathy
0.000 0.998 0.001
B23.0 Acute HIV infection syndrome
0.000 0.998 0.001
T90.1 Sequelae of open wound of head
0.000 0.998 0.001
T93.1 Sequelae of fracture of femur
0.000 0.998 0.001
Y43.4 Immunosuppressive agents
0.000 0.998 0.001
M84.1 Nonunion of fracture [pseudarthrosis]
0.002 0.998 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.998 0.001
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.998 0.001
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.998 0.001
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.998 0.001
Y51.0 Anticholinesterase agents
0.000 0.998 0.001
Y53.2 Stimulant laxatives
0.000 0.998 0.001
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.998 0.001
Y55.5 Anticommon cold drugs
0.000 0.998 0.001
Y55.3 Antitussives
0.000 0.998 0.001
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.998 0.001
Y58.0 BCG vaccine
0.000 0.998 0.001
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.001 0.998 0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)
0.001 0.998 0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)
0.001 0.998 0.000
G95.2 Cord compression, unspecified
0.000 0.998 0.002
I49.3 Ventricular premature depolarisation
0.002 0.998 0.000
T94 Sequelae of injuries involving multiple and unspecified body regions
0.000 0.998 0.001
I95-I99 Other and unspecified disorders of the circulatory system
0.000 0.998 0.002
T93.9 Sequelae of unspecified injury of lower limb
0.000 0.998 0.001
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.000 0.998 0.001
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.998 0.001
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.998 0.001
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.998 0.001
Y47.4 Bromine compounds
0.000 0.998 0.001
Y47.3 Paraldehyde
0.000 0.998 0.001
Y47.2 Chloral derivatives
0.000 0.998 0.001
Y47.0 Barbiturates, not elsewhere classified
0.000 0.998 0.001
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.998 0.001
I98 Other disorders of circulatory system in diseases classified elsewhere
0.000 0.998 0.001
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)
0.000 0.998 0.001
M41.94 Scoliosis, unspecified (Thoracic region)
0.001 0.998 0.000
Y45.4 Antirheumatics
0.000 0.998 0.001
Y55.0 Oxytocic drugs
0.000 0.998 0.001
Y57.8 Other drugs and medicaments
0.000 0.998 0.001
B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases
0.000 0.998 0.001
B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
0.000 0.998 0.001
T90 Sequelae of injuries of head
0.000 0.998 0.001
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.001 0.998 0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.001 0.998 0.000
M62.82 Other specified disorders of muscle (Upper arm)
0.001 0.998 0.000
D37.4 Colon
0.000 0.998 0.001
M62.8 Other specified disorders of muscle
0.001 0.998 0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis
0.001 0.998 0.000
B18.8 Other chronic viral hepatitis
0.000 0.999 0.001
B18.0 Chronic viral hepatitis B with delta-agent
0.000 0.999 0.001
C25.9 Pancreas, unspecified
0.000 0.999 0.001
Y46.2 Hydantoin derivatives
0.000 0.999 0.001
Y53.6 Antidiarrhoeal drugs
0.000 0.999 0.001
Y54.4 Loop [high-ceiling] diuretics
0.000 0.999 0.001
Y55.4 Expectorants
0.000 0.999 0.001
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
0.000 0.999 0.001
I99 Other and unspecified disorders of circulatory system
0.000 0.999 0.001
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.001 0.999 0.000
F20.5 Residual schizophrenia
0.000 0.999 0.001
L89.3 Stage IV decubitus ulcer
0.001 0.999 0.000
T91.3 Sequelae of injury of spinal cord
0.000 0.999 0.001
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.999 0.001
Y53.7 Emetics
0.000 0.999 0.001
Y53.5 Digestants
0.000 0.999 0.001
Y53.0 Histamine H2-receptor antagonists
0.000 0.999 0.001
Y54.5 Other diuretics
0.000 0.999 0.001
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.999 0.001
T91 Sequelae of injuries of neck and trunk
0.000 0.999 0.001
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.001 0.999 0.000
G95.8 Other specified diseases of spinal cord
0.000 0.999 0.001
N30.3 Trigonitis
0.000 0.999 0.001
Y54.7 Agents affecting calcification
0.000 0.999 0.001
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.001 0.999 0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.001 0.999 0.000
B18.9 Chronic viral hepatitis, unspecified
0.000 0.999 0.001
E23.7 Disorder of pituitary gland, unspecified
0.000 0.999 0.001
K04.7 Periapical abscess without sinus
0.001 0.999 0.000
R01.0 Benign and innocent cardiac murmurs
0.000 0.999 0.001
R93.4 Abnormal findings on diagnostic imaging of urinary organs
0.001 0.999 0.000
Y46.8 Antispasticity drugs
0.000 0.999 0.001
Y46.3 Deoxybarbiturates
0.000 0.999 0.001
Y46.1 Oxazolidinediones
0.000 0.999 0.001
Y46.0 Succinimides
0.000 0.999 0.001
Y53.4 Other laxatives
0.000 0.999 0.001
T94.0 Sequelae of injuries involving multiple body regions
0.000 0.999 0.001
Y48.5 Therapeutic gases
0.000 0.999 0.001
Y48.1 Parenteral anaesthetics
0.000 0.999 0.001
Y48.0 Inhaled anaesthetics
0.000 0.999 0.001
Y54.3 Benzothiadiazine derivatives
0.000 0.999 0.001
Y56.9 Topical agent, unspecified
0.000 0.999 0.001
Y56.8 Other topical agents
0.000 0.999 0.001
Y56.7 Dental drugs, topically applied
0.000 0.999 0.001
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.999 0.001
Y56.5 Ophthalmological drugs and preparations
0.000 0.999 0.001
Y56.2 Local astringents and local detergents
0.000 0.999 0.001
Y56.1 Antipruritics
0.000 0.999 0.001
F20 Schizophrenia
0.000 0.999 0.001
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)
0.001 0.999 0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)
0.001 0.999 0.000
G95.1 Vascular myelopathies
0.000 0.999 0.001
L08.9 Local infection of skin and subcutaneous tissue, unspecified
0.001 0.999 0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified
0.001 0.999 0.000
M06.3 Rheumatoid nodule
0.001 0.999 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.000 0.999 0.001
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.001 0.999 0.000
M62.81 Other specified disorders of muscle (Shoulder region)
0.001 0.999 0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)
0.001 0.999 0.000
I97.2 Postmastectomy lymphoedema syndrome
0.000 0.999 0.001
O80.9 Single spontaneous delivery, unspecified
0.001 0.999 0.000
T13.0 Superficial injury of lower limb, level unspecified
0.000 0.999 0.001
T78.1 Other adverse food reactions, not elsewhere classified
0.000 0.999 0.001
Y53.3 Saline and osmotic laxatives
0.000 0.999 0.001
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.999 0.001
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.001 0.999 0.000
M79.80 Other specified soft tissue disorders (Multiple sites)
0.001 0.999 0.000
F20.8 Other schizophrenia
0.000 0.999 0.001
H59.8 Other postprocedural disorders of eye and adnexa
0.000 0.999 0.001
I95.1 Orthostatic hypotension
0.000 0.999 0.001
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere
0.000 0.999 0.001
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere
0.000 0.999 0.001
I98.0 Cardiovascular syphilis
0.000 0.999 0.001
T90.5 Sequelae of intracranial injury
0.000 0.999 0.001
T92.3 Sequelae of dislocation, sprain and strain of upper limb
0.000 0.999 0.001
Y48.2 Other and unspecified general anaesthetics
0.000 0.999 0.001
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.999 0.001
Y56.3 Emollients, demulcents and protectants
0.000 0.999 0.001
D45 Polycythaemia vera
0.001 0.999 0.000
M00.94 Pyogenic arthritis, unspecified (Hand)
0.000 0.999 0.001
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)
0.001 0.999 0.000
B21.9 HIV disease resulting in unspecified malignant neoplasm
0.000 0.999 0.001
B21.8 HIV disease resulting in other malignant neoplasms
0.000 0.999 0.001
B21.7 HIV disease resulting in multiple malignant neoplasms
0.000 0.999 0.001
B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.999 0.001
B21.2 HIV disease resulting in other types of non-Hodgkin's lymphoma
0.000 0.999 0.001
B21.1 HIV disease resulting in Burkitt's lymphoma
0.000 0.999 0.001
B21.0 HIV disease resulting in Kaposi's sarcoma
0.000 0.999 0.001
B22.7 HIV disease resulting in multiple diseases classified elsewhere
0.000 0.999 0.001
B22.2 HIV disease resulting in wasting syndrome
0.000 0.999 0.001
B22.1 HIV disease resulting in lymphoid interstitial pneumonitis
0.000 0.999 0.001
B22.0 HIV disease resulting in encephalopathy
0.000 0.999 0.001
G95.0 Syringomyelia and syringobulbia
0.000 0.999 0.001
K74.0 Hepatic fibrosis
0.001 0.999 0.000
M06.0 Seronegative rheumatoid arthritis
0.001 0.999 0.000
Y46.6 Other and unspecified antiepileptics
0.000 0.999 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.